Log In
BCIQ
Print this Print this
 

MD707

  Manage Alerts
Collapse Summary General Information
Company Effimune S.A.S.
DescriptionAnti CD-127 antibody
Molecular Target Interleukin-7 (IL-7) receptor (CD127)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Transplant (unspecified)
Indication DetailsPrevent transplant rejection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$33.7M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/24/2016

$33.7M

0

0

Get a free BioCentury trial today